cytidine monophosphate has been researched along with Acute Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bendavit, GG; Cohen, JC; Geller, M; Higashi, R; Mibielli, MA; Nunes, CP; Oliveira, L; Scussel, AB | 1 |
| Cailla, HL; Carcassonne, Y; Gastaut, JA; Maraninchi, D; Scavennec, J | 1 |
| Harada, M; Isokawa, M; Kimura, F; Kojima, K; Ohmoto, E; Takaba, S; Takeuchi, M; Tanimizu, M | 1 |
| Kamiya, K; Kawai, Y; Nakamura, T; Sugiyama, M; Tsutani, H; Ueda, T; Urasaki, Y; Wataya, S | 1 |
| Higa, T; Kasai, M; Kiyama, Y; Kobayashi, N; Masauzi, N; Naohara, T; Ogasawara, M; Ohizumi, H; Saito, M; Suzuki, G | 1 |
| Braess, J; Freund, M; Hanauske, A; Heil, G; Hiddemann, W; Kaufmann, C; Kern, W; Schleyer, E; Schüssler, M | 1 |
| Deguchi, K; Kageyama, S; Komada, F; Minami, N; Morita, K; Nishikawa, M; Shirakawa, S; Uemura, Y | 1 |
| Kimura, I; Kimura, K; Masaoka, T; Nakamura, T; Ohno, R; Ohshima, T; Tatsumi, N; Yamada, K | 1 |
| Kamiya, K; Nakamura, T; Sugiyama, M; Tanaka, T; Tsutani, H; Ueda, T; Wano, Y | 1 |
| Grisé-Miron, L; Labonté, L; Leclerc, JM | 1 |
4 trial(s) available for cytidine monophosphate and Acute Disease
| Article | Year |
|---|---|
Treatment of acute, non-traumatic pain using a combination of diclofenac-cholestyramine, uridine triphosphate, cytidine monophosphate, and hydroxycobalamin.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cholestyramine Resin; Cytidine Monophosphate; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxocobalamin; Male; Middle Aged; Pain; Uridine Triphosphate | 2010 |
[Treatment of refractory hematologic malignancies by combination of cytarabine ocfosfate and etoposide].
Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia; Male; Middle Aged | 1996 |
Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics.
Topics: Acute Disease; Administration, Oral; Adult; Antineoplastic Agents; Arabinonucleotides; Biological Availability; Cytarabine; Cytidine Monophosphate; Diarrhea; Dose-Response Relationship, Drug; Half-Life; Humans; Infusions, Intravenous; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Prodrugs; Regression Analysis | 1998 |
[Phase II study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate) on hematological malignancies].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Drug Administration Schedule; Drug Evaluation; Female; Humans; Japan; Leukemia; Male; Middle Aged; Myelodysplastic Syndromes; Nausea; Remission Induction; Vomiting | 1990 |
6 other study(ies) available for cytidine monophosphate and Acute Disease
| Article | Year |
|---|---|
Purine and pyrimidine ribonucleoside monophosphate patterns of peripheral blood and bone marrow cells in human acute leukemias.
Topics: Acute Disease; Adenosine Monophosphate; Adult; Aged; Bone Marrow; Cytidine Monophosphate; Erythrocytes; Female; Guanosine Monophosphate; Humans; Leukemia; Male; Middle Aged; Ribonucleotides; Uridine Monophosphate | 1982 |
[Successful treatment of refractory anemia with excess of blasts in transformation with cytarabine ocfosfate].
Topics: Acute Disease; Administration, Oral; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Female; Humans; Leukemia; Middle Aged | 1995 |
Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine.
Topics: Acute Disease; Adult; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Polycythemia Vera | 1994 |
[A case of complete remission from acute unclassified leukemia achieved by using a prodrug of ara C, stearyl-ara-CMP (YNK01)].
Topics: Acute Disease; Administration, Oral; Antineoplastic Agents; Arabinonucleotides; Cytarabine; Cytidine Monophosphate; Drug Administration Schedule; Female; Humans; Leukemia; Middle Aged; Prodrugs; Remission Induction | 1990 |
[Pharmacokinetics of stearyl-ara-CMP (YNK-01) in patients with hematologic neoplasms].
Topics: Acute Disease; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Cytosine Nucleotides; Drug Evaluation; Humans; Leukemia; Myelodysplastic Syndromes | 1989 |
Inhibition of DNA polymerase-alpha by ara-CMP in the presence of a regulatory protein extracted from human promyelocytic leukemic cells (HL-60).
Topics: Acute Disease; Arabinonucleotides; Cell Line; Cytidine Monophosphate; Cytosine Nucleotides; Deoxycytidine Monophosphate; DNA Polymerase II; DNA-Binding Proteins; Humans; Leukemia; Leukemia, Myeloid, Acute; Molecular Weight; Uridine Monophosphate | 1987 |